Table 1.

Baseline characteristics

	Cetuximab + TP (n = 74)	TP (n = 78)
Age (years)
Median (range)	61 (44–78)	60.5 (40–76)
Sex
Male	62 (83.8%)	69 (88.5%)
Female	12 (16.2%)	9 (11.5%)
ECOG
0	33 (44.6%)	33 (42.3%)
1	41 (55.4%)	45 (57.7%)
Number of metastases
1	16 (21.6%)	3 (28.2%)
≥2	58 (78.4%)	5 (71.8%)
Tumor location
Upper	9 (12.2%)	7 (9.0%)
Middle	36 (48.6%)	31 (39.7%)
Lower	23 (31.1%)	35 (44.9%)
NA	6 (8.1%)	5 (6.4%)
Previous surgery
Yes	27 (36.5%)	27 (34.6%)
No	47 (63.5%)	51 (65.4%)
Previous radiotherapy
Yes	17 (23.0%)	21 (26.9%)
No	57 (77.0%)	57 (73.1%)